CD8A and neoplasm: For instance, losartan normalizes the TME in PC by decreasing fibrosis and improving drug delivery [361], while galunisertib synergizes with M7824 in CRC to enhance CD8 + T-cell infiltration and suppress tumor growth [362, 363].